‘Pharma burnout’: Industry reputation slumps in first half of 2022, study finds
Industry Specific Insights31 Oct, 2022
"The biopharma industry reputation is sliding again — and alarmingly fast. The pharmaceuticals, biotechnology and life sciences category fell almost 3 points (2.9) between the first and second quarter of 2022, according to corporate reputation monitor RepTrak."
